How should I obtain and interpret a urinalysis, including dip‑stick and microscopic examination, and manage any abnormal findings?

Urinalysis: Obtaining and Interpreting Results

Obtain urine specimens using clean-catch midstream technique for adults and catheterization or suprapubic aspiration for febrile infants under 24 months when urinary tract infection is suspected, and always confirm positive dipstick results with microscopic examination showing ≥3 RBCs/HPF before initiating further evaluation. 1, 2

Specimen Collection Methods

Adults

• Clean-catch midstream urine is the standard collection method 3
• The specimen must be fresh: examine within 1 hour at room temperature or within 4 hours if refrigerated 1
• Avoid bag specimens in adults—they have unacceptably high contamination rates

Febrile Infants (2-24 months)

• Catheterization or suprapubic aspiration (SPA) are the only acceptable methods for culture when UTI is suspected 1, 4
• Bag specimens can be used for initial screening in clinically stable infants, but positive leukocyte esterase or nitrites require confirmation with catheterized specimen 1
• Catheterization is preferred over SPA as it causes less distress 4

Dipstick Interpretation

Key Performance Characteristics

Leukocyte Esterase:

• Sensitivity: 83% (range 67-94%)
• Specificity: 78% (range 64-92%)
• Detects pyuria as a marker of true UTI, not just asymptomatic bacteriuria 1

Nitrite:

• Sensitivity: 53% (range 15-82%)
• Specificity: 98% (range 90-100%)
• Critical limitation: Requires 4 hours of bladder incubation, making it insensitive in infants who void frequently 1
• When positive, highly specific for bacterial infection 1

Combined Testing:

• Either leukocyte esterase OR nitrite positive: 93% sensitivity, 72% specificity
• All three tests (LE, nitrite, microscopy) positive: 99.8% sensitivity 1

Other Dipstick Parameters

• Specific gravity: Indicates hydration status 3
• pH: Reflects diet, metabolism, or stone presence 3
• Protein: Requires quantitative follow-up (spot urine albumin/creatinine ratio) if positive 3
• Glucose: Suggests uncontrolled diabetes 3
• Bilirubin/urobilinogen: May indicate hepatobiliary disease or hemolysis 3

Microscopic Examination Requirements

When to Perform Microscopy

Always confirm dipstick hematuria with microscopy before initiating evaluation—dipstick measures peroxidase activity and has false positives from povidone iodine, myoglobinuria, and dehydration 5, 2

Defining Abnormal Results

Hematuria:

• ≥3 RBCs/HPF on microscopic examination from 2 of 3 properly collected specimens defines microhematuria 6
• Single positive dipstick with negative microscopy: Repeat 3 times; if all negative on microscopy, no further workup needed 7
• Gross hematuria: Always warrants full urologic evaluation regardless of whether self-limited 2

Pyuria:

• Presence of WBCs distinguishes true UTI from asymptomatic bacteriuria 1
• For UTI diagnosis in infants: Requires both pyuria/bacteriuria on urinalysis and ≥50,000 CFU/mL on culture from catheterized specimen 1

Bacteriuria:

• Gram stain of uncentrifuged urine showing any bacteria: 93% sensitivity, 4% false-positive rate 8
• Centrifugation decreases specificity due to debris appearing as bacteria 8

Managing Abnormal Findings

Hematuria Workup

Risk Stratification for Malignancy 9, 2:

• High-risk factors: Gross hematuria (30-40% malignancy risk), age >35 years, male gender, smoking, occupational chemical exposure, analgesic abuse, irritative voiding symptoms, pelvic irradiation history, chronic UTI, chronic indwelling catheter
• Low-risk: Microhematuria without risk factors (2.6-4% malignancy risk)

Evaluation Algorithm:

1. Rule out benign causes first 5, 7:

   • Vigorous exercise, menstruation, recent urologic procedure, trauma
   • UTI: Confirm with urine culture before attributing hematuria to infection; repeat urinalysis after treatment to confirm resolution 5
   • Medical renal disease indicators: Proteinuria >2+, RBC casts, dysmorphic RBCs, hypertension 10

2. If benign cause identified: Repeat urinalysis after resolution; if hematuria persists, proceed with risk-based evaluation 5

3. Persistent hematuria without benign cause:

   • Gross hematuria: Immediate urologic referral for cystoscopy and imaging 2
   • Microhematuria with risk factors: Urologic referral for cystoscopy and imaging 2
   • Microhematuria without risk factors: Consider urologic referral based on shared decision-making 2

4. Anticoagulation is NOT a reason to defer evaluation—these patients have similar malignancy risk 5, 2

5. Do NOT obtain urinary cytology or molecular markers in initial hematuria evaluation 2

UTI Management

Febrile Infants (2-24 months) 1, 4:

• Positive urinalysis (LE or nitrite or microscopy showing WBCs/bacteria) + ≥50,000 CFU/mL on catheterized culture = confirmed UTI
• Start antimicrobials based on local sensitivity patterns (oral or parenteral acceptable)
• Asymptomatic bacteriuria (positive culture without pyuria): Do NOT treat—may cause more harm than good 1

Adults 3:

• Symptomatic UTI: Nitrites more specific; positive LE may reflect inflammation
• Asymptomatic bacteriuria: Do NOT treat in most patients—only treat in pregnancy or before endoscopic urologic procedures 3

Proteinuria Follow-up

• Dipstick-positive proteinuria requires quantitative testing with spot urine albumin/creatinine ratio 3
• Persistent proteinuria with hematuria suggests glomerular disease—nephrology referral indicated 5

Common Pitfalls to Avoid

1. Never rely on dipstick alone for hematuria diagnosis—always confirm with microscopy 2, 5
2. Never attribute hematuria to UTI without culture confirmation, especially before antibiotic treatment 5, 7
3. Never defer hematuria evaluation in anticoagulated patients 5, 2
4. Never use bag specimens for urine culture in infants—only catheterization or SPA 1
5. Never screen asymptomatic adults for cancer with urinalysis 2
6. Never treat asymptomatic bacteriuria except in pregnancy or pre-procedure 1, 3
7. Never assume hematuria resolved without repeat urinalysis after treating presumed benign cause 5